Beth-Israel Deaconess Medical Center — Boston, Massachusetts

Beth-Israel Deaconess Medical Center is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Clinical Trials Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Beth-Israel Deaconess Medical Center has participated in 16 clinical trials with 6 currently active.

Therapeutic areas: Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma.

Sponsors: Massachusetts General Hospital, Dana-Farber Cancer Institute, Patrick C. Johnson, MD.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth-Israel Deaconess Medical Center?

Beth-Israel Deaconess Medical Center has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth-Israel Deaconess Medical Center conducted?

Beth-Israel Deaconess Medical Center has 16 clinical trials on record, with 6 currently active. Their work covers Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma.

Is Beth-Israel Deaconess Medical Center accredited by Crixeo Clinical Trials?

Beth-Israel Deaconess Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth-Israel Deaconess Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.